Aspire Biopharma Holdings, Inc.
ASBPW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.88K
Close$
$-0.25
1739.9% downside
Current Fair Value
1739.9% downsideOvervalued by 1739.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15,879.00 |
|---|---|
| Enterprise Value | $-12,151,257.00 |
| Earnings per Share | $-16.38 |
| Beta | 0.15 |
| Outstanding Shares | 1,037,874 |
Return
| Return on Equity | -93.98% |
|---|---|
| Return on Assets | -81.60% |
| Return on Invested Capital | -61.97% |
Valuation & Multiples
| P/E Ratio | -1.1 |
|---|---|
| PEG | 3.05 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 610.11 |
| Enterprise Value to EBIT | -8.11 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 275,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 651.68%▲ 635.97% |
|---|---|
| Total Invested | $145,434▼ 3.37% |
| Investors Holding | 28▼ 1.00% |
About Aspire Biopharma Holdings, Inc.
2 employees
CEO: Mr. Kraig T. Higginson
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge resear...